High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma
Clinical trial NCT02597062 · COMPLETED
Trial details
- NCT number
- NCT02597062
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-05
- Primary completion
- 2019-06-19
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.